Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-03, Stock:ABBV, The news for the past five days is as follows:
2019-04-26: NEWS1: Edited Transcript of ABBV earnings conference call or presentation 25-Apr-19 1:00pm GMT.NEWS2: 2 Large Drug Manufacturers Release 1st-Quarter Results.NEWS3: Gut Check: The Bacteria In Your Intestines Could Help Cure Cancer.NEWS4: 3 Big Stock Charts for Friday: AbbVie, ConocoPhillips and MGM Resorts.NEWS5: 3 Big Stock Charts for Friday: AbbVie, ConocoPhillips and MGM Resorts.NEWS6: 3 Big Stock Charts for Friday: AbbVie, ConocoPhillips and MGM Resorts.
2019-04-29: NEWS1: Better Big Pharma Stock: AbbVie vs. AstraZeneca.NEWS2: Better Big Pharma Stock: AbbVie vs. AstraZeneca.NEWS3: Better Big Pharma Stock: AbbVie vs. AstraZeneca.NEWS4: AbbVie Raises EPS Guidance for Fiscal 2019.NEWS5: AbbVie Reiterates Revenue Guidance for Fiscal 2019.NEWS6: What Analysts Are Recommending for AbbVie after Q1 Results.NEWS7: 3 Reasons Why Growth Investors Shouldn't Overlook AbbVie (ABBV).NEWS8: 3 Reasons Why Growth Investors Shouldn't Overlook AbbVie (ABBV).NEWS9: AbbVie (ABBV) Upgraded to Buy: Here's Why.NEWS10: AbbVie (ABBV) Upgraded to Buy: Here's Why.NEWS11: Why AbbVie (ABBV) is a Great Dividend Stock Right Now.NEWS12: Why AbbVie (ABBV) is a Great Dividend Stock Right Now.NEWS13: Why AbbVie (ABBV) is a Great Dividend Stock Right Now.NEWS14: A Look at Cosentyx, Novartis’s Fast-Growing Immunology Drug.NEWS15: AbbVie (ABBV) Upgraded to Buy: Here's Why.NEWS16: 3 Reasons Why Growth Investors Shouldn't Overlook AbbVie (ABBV).NEWS17: Here are the biggest analyst calls of the day: Target, Disney, CVS, American Airlines, & more.NEWS18: Here are the biggest analyst calls of the day: Target, Disney, CVS, American Airlines, & more.
2019-04-30: NEWS1: Financial Exchange Stock Talk: Dividend Sensei On AbbVie.NEWS2: Financial Exchange Stock Talk: Dividend Sensei On AbbVie.NEWS3: Top Stock Reports for Facebook, Comcast & AbbVie.NEWS4: Neurocrine Biosciences Has Robust Late-Stage Pipeline.NEWS5: European Commission Approves SKYRIZI™ (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis.NEWS6: AbbVie’s Guidance for Second Quarter of Fiscal 2019.NEWS7: AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson's Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting.
2019-05-01: NEWS1: Profit from Earnings Volatility With This Biotech Stocks Pairs Trade.NEWS2: Profit from Earnings Volatility With This Biotech Stocks Pairs Trade.NEWS3: Profit from Earnings Volatility With This Biotech Stocks Pairs Trade.NEWS4: The Zacks Analyst Blog Highlights: Facebook, Comcast, AbbVie, Union Pacific and Air Products.NEWS5: The Zacks Analyst Blog Highlights: Facebook, Comcast, AbbVie, Union Pacific and Air Products.NEWS6: The Zacks Analyst Blog Highlights: Facebook, Comcast, AbbVie, Union Pacific and Air Products.
2019-05-02: NEWS1: These 6 biotech stocks are promising takeover targets.

Answer: Rise